Advertisement

Understanding Evidence-Based Rheumatology

A Guide to Interpreting Criteria, Drugs, Trials, Registries, and Ethics

  • Hasan Yazici
  • Yusuf Yazici
  • Emmanuel Lesaffre

Table of contents

  1. Front Matter
    Pages i-xii
  2. Hasan Yazici, Yusuf Yazici
    Pages 65-78
  3. Mehmet Tevfik Dorak, Yusuf Yazici
    Pages 79-126
  4. Yusuf Yazici, Hilal Maradit Kremers
    Pages 127-140
  5. Hilal Maradit Kremers, Banu Çakir
    Pages 141-157
  6. Theo Stijnen, Gulen Hatemi
    Pages 229-246
  7. Hasan Yazici, Emmanuel Lesaffre, Yusuf Yazici
    Pages 247-263
  8. Hasan Yazici, Yusuf Yazici, Emmanuel Lesaffre
    Pages 265-268
  9. Back Matter
    Pages 269-276

About this book

Introduction

It is imperative that health professionals caring for patients with rheumatic diseases understand how to correctly interpret evidence in their field, taking into account the merits and shortcomings of available data. Understanding Evidence-Based Rheumatology offers a practical assessment of criteria, drugs, trials, and registries and provides useful tools for successfully interpreting this data. The book introduces readers to basic analysis of trial design, statistics, and application of data through no-nonsense, easy-to-follow insights. Using numerous examples, chapters outline the difficulties physicians encounter when measuring disease activity in rheumatology, and offer strategies for systematically approaching these situations. Ethical issues in study design and reporting are examined, and the book closes with a summary of future directions for scientific and clinical studies in rheumatology.

Understanding Evidence-Based Rheumatology is an invaluable resource for trainees, experienced clinicians, and scientists, preparing them with the necessary tools to correctly gather evidence and shed light on the difficult practice of rheumatology.

 

Keywords

Biomarkers Criteria Data collection Outcome measures Rheumatology data Trials

Editors and affiliations

  • Hasan Yazici
    • 1
  • Yusuf Yazici
    • 2
  • Emmanuel Lesaffre
    • 3
  1. 1.Istanbul UniversityBeyazit, IstanbulTurkey
  2. 2.New York University School of Medicine, NYU Hospital for Joint DiseasesNew YorkUSA
  3. 3.Department of BiostatisticsL-Biostat, KU Leuven, Leuven, Belgium, and Erasmus MCRotterdamThe Netherlands

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-319-08374-2
  • Copyright Information Springer International Publishing Switzerland 2014
  • Publisher Name Springer, Cham
  • eBook Packages Medicine
  • Print ISBN 978-3-319-08373-5
  • Online ISBN 978-3-319-08374-2
  • Buy this book on publisher's site
Industry Sectors
Pharma
Biotechnology